Nov 4, 2019
KaloCyte CEO to Present at NIH Innovation Conference and Life Sciences Summit Company Continues Momentum Following Recent Relocation to Baltimore BALTIMORE, Md., November 4, 2019 – KaloCyte, Inc., a preclinical-stage healthcare biotechnology company developing a...
Oct 30, 2019
University of Maryland Medicine Bulletin Fall 2019 – Vol.104 – Number 2 Bold New Vision on Blood Research By: Christiana McCausland Each year there are perhaps as many as 20,000 preventable deaths caused by blood loss in the United States. In the U.S....
Oct 25, 2019
The Daily Record Why KaloCyte Picked Baltimore and the BioPark By: Tim Curtis The Daily Record Business Writer, October 10, 2019 The University of Maryland BioPark and proximity to key stakeholders were two of the top reasons KaloCyte decided to move to Baltimore,...
Oct 25, 2019
Baltimore Sun St. Louis biotech company moves to Baltimore to develop fake blood for real emergencies By Meredith Cohn|Sep. 23, 2019 A small biotechnology company developing a synthetic blood for use when supplies are low or unavailable is moving to Baltimore from St....
Oct 2, 2019
technical.ly Why Baltimore rose to the ‘top of the list’ when this biotech team needed a new HQ By Stephen Babcock|Sep. 30th, 2019 As announced last week, the team that is commercializing a synthetic blood product relocated from St. Louis to downtown...
Oct 1, 2019
St. Louis biotech KaloCyte joins UM BioPark, consolidates team in Baltimore By Carley Milligan – Sep 24, 2019, 7:47am EDT Digital Editor, Baltimore Business Journal A St. Louis biotechnology company backed by $6 million in funding has relocated to a small space in...
